Skip to content
MarketScale
‹ Back to IndustriesSciences

Bill Gates-Led Fund Backs Startup With Cheaper Way to Move Hydrogen

(Bloomberg) — A hydrogen molecule is tiny. So tiny, in fact, that trying to store and transport it via existing tanks and pipes can end up causing cracks in steel. If hydrogen is to become a clean fuel of the future, urgent technological solutions are needed to keep it in place and move it at…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences ·
Share
Bill Gates-Led Fund Backs Startup With Cheaper Way to Move Hydrogen

Key takeaways

01

(Bloomberg) — A hydrogen molecule is tiny.

02

So tiny, in fact, that trying to store and transport it via existing tanks and pipes can end up causing cracks in steel.

03

If hydrogen is to become a clean fuel of the future, urgent technological solutions are needed to keep it in place and move it at…

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Request an invite

(Bloomberg) —

A hydrogen molecule is tiny. So tiny, in fact, that trying to store and transport it via existing tanks and pipes can end up causing cracks in steel. If hydrogen is to become a clean fuel of the future, urgent technological solutions are needed to keep it in place and move it at will.

Enter H2SITE, a Spanish startup, that promises to do just that. It’s secured 12.5 million euros ($13.23 million) in investments from Bill Gates-led Breakthrough Energy Ventures, French utility Engie SA and Norwegian oil giant Equinor ASA.

While there are existing methods to store and transport hydrogen, they can be prohibitively expensive, especially compared to moving around its carbonaceous cousin natural gas. H2SITE says that transporting hydrogen could cost as much as three times the cost of hydrogen production. The startup offers to provide that service at a fraction of a cost, if its technology can scale.

There are two modes in which H2SITE’s technology works. First is to use existing natural-gas pipelines to move hydrogen from where it’s produced to where it is consumed. These pipes can carry about 30% hydrogen when mixed with natural gas. The idea is that diluted hydrogen will be less corrosive on existing steel infrastructure. Freshly produced hydrogen is injected into a pipeline containing natural gas, close to where hydrogen is made, and then recovered using H2SITE’s filter where it needs to be consumed.

“It’s like being able to separate a great Bordeaux wine after it’s mixed with a common wine,” said Sebastien Arbola, executive vice president at Engie.

No sieve in the world can filter out hydrogen (or separate a Bordeaux from supermarket wine). So H2SITE makes use of some clever chemistry that exploits hydrogen’s liking for certain metals such as palladium. Under the right conditions of heat and pressure, a hydrogen atom on the surface of a palladium alloy can split apart and reform when the temperature and pressure are lower. That means H2SITE can filter hydrogen at 99.9% purity from a pipe carrying between 5% and 30% hydrogen with the rest being natural gas.

That’s not all. If it’s not pipes, hydrogen (H₂) is likely to be moved around in ships — not as itself but trapped within ammonia (NH₃) or methanol (CH₃OH). That’s because ammonia can be easily turned into a liquid and methanol is already a liquid. There are currently projects being developed in countries like Australia that have plenty of space for solar and wind farms where hydrogen is produced, converted to ammonia, moved on ships, and then hydrogen is recovered by undoing the chemical reaction.

Obviously, the process of converting hydrogen to ammonia and back is highly energy intensive. Bringing down the cost of ammonia cracking will be key to making large investments to scale up hydrogen production for exports, according to Anja-Isabel Dotzenrath, executive vice president of gas and low carbon energy at BP Plc. “What we need to address is the cost of ammonia cracking,” Dotzenrath said in a recent interview about the company’s plans for a green hydrogen hub in Australia.

H2SITE’s second mode of operation causes it to become a cracker for ammonia or methanol. All that needs to be done, according to Andrés Galnares, H2SITE’s chief executive officer, is to increase the number of palladium membranes and tweak the temperature and pressure at which the reactor is run.

“It is early days” for H2SITE, said Arbola. The startup has reactors that can be used to filter out 40 kilograms of hydrogen per day, whereas its commercial units will be able to handle 200kg and 500kg respectively. Once scaled up, Galnares says that the cost of filtering the clean-burning fuel will be about $0.80 per kilogram of hydrogen.

The startup already has three sites where the technology will be tested. In the UK, ammonia made with renewable hydrogen will be converted to hydrogen. In Spain, a consortium of energy companies and research centers will test the generation, injection and transportation of hydrogen, with H2SITE providing reactors for filtering. In France, H2SITE’s reactors will generate hydrogen for vehicles.

Engie’s Arbola is clear that in building out hydrogen infrastructure or repurposing existing pipelines, it’s important to ensure that hydrogen doesn’t leak. That’s because, while hydrogen isn’t a greenhouse gas, it can extend the life of existing potent warming gases like methane or cause the production of another greenhouse gas ozone.

With natural gas prices at such highs, clean energy research group BloombergNEF finds that green hydrogen is now cheaper than natural gas in eight European countries. That means you can expect more startups with technologies that work to make the hydrogen economy a reality.

–With assistance from Will Mathis.

To contact the author of this story:

Akshat Rathi in London at arathi39@bloomberg.net

More stories like this are available on bloomberg.com

© 2022 Bloomberg L.P.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

Bristol Myers exits Cellares deal, putting standardized cell therapy capacity in doubt

Bristol Myers exits Cellares deal, putting standardized cell therapy capacity in doubt

Bristol Myers has terminated its agreement with Cellares, which raises concerns about the standardized capacity for cell therapy production. This decision highlights the importance of aligning manufacturing processes with production capabilities, rather than merely focusing on the availability of factory slots.

  • 01Bristol Myers has terminated its agreement with Cellares, affecting cell therapy capacity.
  • 02Aligning process fit with production capabilities is crucial for cell therapy success.
  • 03Factory slots alone are not sufficient to ensure supply plans in cell therapy production.

Aug 26, 2026

Argonne’s AI agents push materials R&D toward days-long cycles

Argonne’s AI agents push materials R&D toward days-long cycles

Argonne National Laboratory is utilizing AI agents to accelerate materials R&D cycles, reducing the time span to just a few days. This advancement hinges on prioritizing dataflow and security over larger AI models. The novel approach aims to streamline processes and enhance the efficiency of research and development activities.

  • 01Argonne National Laboratory is using AI agents to significantly shorten materials R&D cycles.
  • 02The focus of procurement has shifted to dataflow and security rather than larger AI models.
  • 03Improved workflows facilitate more efficient research and development efforts.

Aug 25, 2026

Cancer diagnostics growth is forcing labs to budget for data, not just instruments

Cancer diagnostics growth is forcing labs to budget for data, not just instruments

The growth in cancer diagnostics is prompting laboratories to allocate budgets not only for instruments but also for data management. Market forecasts predict an increase in the cancer diagnostics market from $29.86 billion in 2026 to $44.92 billion by 2031. Staffing is identified as a significant operational constraint according to industry insights.

  • 01Cancer diagnostics market is expected to grow from $29.86 billion in 2026 to $44.92 billion by 2031.
  • 02Laboratories are increasingly required to budget for data management alongside instruments.
  • 03Staffing is a major operational constraint in the growth of cancer diagnostics.

Aug 24, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512